Lexology November 21, 2025
Decision marks another in a string of cases in which courts dive into an issue before evidence is fully gathered.
Private equity firm GTCR LLC is poised to complete its $627 million acquisition of Surmodics Inc., a leading supplier of medical device coatings, after a federal judge denied the Federal Trade Commission’s request for a preliminary injunction.
The ruling, delivered from the bench by U.S. Judge Jeffrey Cummings in Chicago on Nov. 10, marks the first litigated merger challenge during President Trump’s second term and a setback for the FTC’s enforcement strategy in healthcare markets.
A significant factor in the judge’s decision was that many of the major original equipment manufacturers (OEMs) of medical devices have their own coating capabilities,...
Today's Sponsors
Today's Sponsor